Literature DB >> 10691831

Priapism in adult Nigerians.

A E Aghaji1.   

Abstract

OBJECTIVES: To review the presentation and treatment of adult Nigerians with priapism. PATIENTS AND METHODS: Thirty-five men (mean age 35 years, range 20-54) were seen over a 12-year period. All patients underwent an immediate modified or conventional cavernospongiosus shunt and were assessed at 2, 6 and 12 weeks after discharge for erection, orgasm and fibrosis of corpora cavernosa.
RESULTS: Ten patients initially presented to traditional healers and 13 presented early to qualified medical practitioners, and were managed conservatively. As a result, 21 of the 35 patients presented to the author's hospital 6-10 days after the onset of erection. Many did not realise that priapism was abnormal, or had no money to attend hospital. After surgical treatment detumescence was obtained in all patients and maintained. At 12 weeks, 14 patients had normal erections, 13 reduced erections and eight no erections. A local aphrodisiac was identified as the commonest predisposing factor, followed by sickle-cell disease.
CONCLUSION: This study shows clearly that even if a patient with priapism presents late, vigorous treatment in the form of an adequate shunt should be undertaken as soon as possible, as this is the only chance the patient has to regain potency.

Entities:  

Mesh:

Year:  2000        PMID: 10691831     DOI: 10.1046/j.1464-410x.2000.00561.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Management of priapism in adult men.

Authors:  Onyeanunam N Ekeke; Hannah E Omunakwe; Ndu Eke
Journal:  Int Surg       Date:  2015-03

2.  Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center.

Authors:  Manoj Kumar; Gaurav Garg; Ashish Sharma; Siddharth Pandey; Manmeet Singh; Satya Narayan Sankhwar
Journal:  Turk J Urol       Date:  2019-02-20

Review 3.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

Review 4.  Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines panel.

Authors:  S Minhas; A Salonia; U Milenkovic; A Cocci; R Veeratterapillay; K Dimitropoulos; L Boeri; P Capogrosso; N C Cilesiz; M Gul; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; M I Omar; C Bettocchi; J Carvalho; Y Yuhong; G Corona; H Jones; A Kadioglu; J I Martinez-Salamanca; P Verze; E C Serefoglu
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

5.  Prevalence of Priapism and Its Awareness amongst Male Homozygous Sickle Cell Patients in Lagos, Nigeria.

Authors:  Adewumi Adediran; Kikelomo Wright; Akinsegun Akinbami; Adedoyin Dosunmu; Olajumoke Oshinaike; Bodunrin Osikomaiya; Sarah Ajibola; Kamal Ismail; Ebele Uche; Olaitan Ojelabi
Journal:  Adv Urol       Date:  2013-07-15

6.  Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficacious.

Authors:  Koffi Mawuse Guedenon; Mawouto Fiawoo; Djatougbe Ayaovi Elie Akolly; Etse Akpako; Balakibawi Esso; Fidèle Comlan Dossou; Adama Dodji Gbadoe
Journal:  EJHaem       Date:  2022-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.